Authors
Latest:
Dr. Kurnit on Adjuvant Chemotherapy Regimens in Mucinous Ovarian CancerKatherine Kurnit, MD, OBGYN oncology fellow at the University of Texas MD Anderson Cancer Center, compares the benefit of gastrointestinal-based versus gynecologic-based adjuvant chemotherapy regimens in patients with mucinous ovarian cancer.
Latest:
Dr. Van Loon Discusses the Management of Rectal CancerKatherine Van Loon, MD, gastrointestinal cancer specialist, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses the management of rectal cancer.
Latest:
Dr. Virgo Shares the Results of the PCP/MO Barriers StudyDr. Virgo From American Cancer Society Shares the Results of the PCP/MO Barriers Study
Latest:
Promoting HPV Vaccination for Girls and BoysOncology nurses can lead the way in efforts to protect the next generation from this type of cancer if they know the facts about HPV vaccination for both girls and boys
Latest:
Dr. Essel Discusses Adverse Events of Bevacizumab in Ovarian CancerKathleen Essel, MD, fellow, University of Oklahoma Health Science Center, discusses adverse events with bevacizumab (Avastin) in ovarian cancer.
Latest:
Dr. Essel on Rationale to Explore Quantitative CT Image Feature Analysis in Gynecologic CancersKathleen G. Essel, MD, discusses the rationale to explore quantitative computed tomography image feature analysis in gynecologic cancers.
Latest:
Compassion Fatigue: When Caring Takes Its TollEvery day, oncology nurses provide care to patients who rely on them not only for their physical care, but also emotional and even spiritual care.
Latest:
Dr. O'Connor on Ongoing Breast Cancer ResearchKathleen L. O'Connor, MD, professor, associate director of Cancer Education, Department of Molecular and Cellular Biochemistry, University of Kentucky Markey Cancer Center, discusses the ongoing research in the field of breast cancer.
Latest:
Dr. Kathleen Foley on the Goal for Cancer Pain ManagementKathleen M. Foley, MD, from Memorial Sloan-Kettering Cancer Center, on the history and future goals for cancer pain management.
Latest:
Using Steroids to Manage Immunotherapy-Associated AEs in MelanomaKathleen Madden, FNP, MSN, AOCNP, APHN, discusses how to judiciously use steroids to manage adverse events in patients with melanoma who are receiving immunotherapy.
Latest:
Kathleen Madden on the Importance of Patient EducationKathleen Madden, from NYU Langone Medical Center, on the Importance Educating Patients About Ipilimumab's Side Effects.
Latest:
Dr. Mahoney on Potential of VISTA-Targeting Therapy in RCCKathleen Mahoney, MD, PhD, discusses the potential of targeting V-domain immunoglobulin containing suppressor of T-cell activation in renal cell carcinoma.
Latest:
Dr Moore on AEs Associated With ADC Treatment in Gynecologic CancersKathleen N. Moore, MD, MS, discusses adverse effects associated with the use of antibody-drug conjugates for the treatment of gynecologic cancers.
Latest:
Dr. Toomey on the Importance of De-Escalation Clinical Trials in HER2+ Breast CancerKathleen C. Toomey, medical oncologist, discusses the importance of clinical trials evaluating de-escalated treatment strategies in HER2-positive breast cancer.
Latest:
Dr Gold on the Benefit of Targeted Therapies in Mutated Lung CancersKathryn A. Gold, MD, discusses the benefit of targeted therapies in patients with mutated lung cancers.
Latest:
A Comprehensive Look at Palliative Care: What Every Fellow Should UnderstandKathryn Bollin, MD, writes about the importance of enlisting palliative care at the right time, as a critical step that must be taken by any team striving to provide expert cancer care.
Latest:
Survivorship Care Plans: Should Every Patient Have One?The number of cancer survivors in the United States has quadrupled since 1971, making it imperative for healthcare professionals to identify and address the needs of this burgeoning population.
Latest:
Kathryn Ciccolini Discusses the CREAM Principles to Manage Dermatologic AEsKathryn Ciccolini, RN, BSN, OCN, DNC, Memorial Sloan Kettering Cancer Center, discusses the concept she developed to manage dermatologic adverse events for patients with cancer.
Latest:
Dr Beckermann on Targeting TREM2 in the Treatment of ccRCCKathryn Beckermann, MD, PhD, discusses ongoing studies investigating the role of TREM2 in the treatment of patients with clear cell renal cell carcinoma.
Latest:
Dr. Hudson on the Utility of Liquid Biopsy in Lung CancerKathryn E. Hudson, MD, discusses the utility of liquid biopsy in lung cancer.
Latest:
Dr. Kolibaba on Efficacy of Entospletinib in Mantle Cell LymphomaKathryn Kolibaba, MD, co-chair, Hematology Research Committee, US Oncology Research, discusses why the Syk inhibitor entospletinib demonstrates efficacy in patients with mantle cell lymphoma (MCL).
Latest:
Dr. Mileham Discusses Biomarkers in Lung CancerKathryn Mileham, MD, medical oncologist, Levine Cancer Institute, Carolinas HealthCare System, discusses biomarkers in lung cancer.
Latest:
Dr. Ruddy on the Use of GnRH Agonists in Breast CancerKathryn Ruddy, MD, discusses the use of GnRH agonists in breast cancer.
Latest:
Nivolumab/Radiotherapy Combo Well-Tolerated in Newly Diagnosed GBMTreatment with nivolumab and radiotherapy with or without concurrent temozolomide was well tolerated and showed promising signs of efficacy for patients with newly-diagnosed glioblastoma multiforme.
